Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
26624 | 204 | 39.0 | 66% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DEXANABINOL | Author keyword | 8 | 60% | 4% | 9 |
2 | HU 211 | Author keyword | 5 | 55% | 3% | 6 |
3 | NONPSYCHOTROPIC CANNABINOIDS | Author keyword | 1 | 100% | 1% | 2 |
4 | TR LEE OCULAR PHARMACOL | Address | 1 | 50% | 1% | 2 |
5 | ANANDAMIDES | Author keyword | 1 | 30% | 1% | 3 |
6 | CB1R | Author keyword | 1 | 13% | 3% | 6 |
7 | AUTOTOMY BEHAVIOR | Author keyword | 1 | 50% | 0% | 1 |
8 | BIBENZYL CANNABINOID | Author keyword | 1 | 50% | 0% | 1 |
9 | CANNABINOID | Address | 1 | 50% | 0% | 1 |
10 | CB RECEPTOR | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DEXANABINOL | 8 | 60% | 4% | 9 | Search DEXANABINOL | Search DEXANABINOL |
2 | HU 211 | 5 | 55% | 3% | 6 | Search HU+211 | Search HU+211 |
3 | NONPSYCHOTROPIC CANNABINOIDS | 1 | 100% | 1% | 2 | Search NONPSYCHOTROPIC+CANNABINOIDS | Search NONPSYCHOTROPIC+CANNABINOIDS |
4 | ANANDAMIDES | 1 | 30% | 1% | 3 | Search ANANDAMIDES | Search ANANDAMIDES |
5 | CB1R | 1 | 13% | 3% | 6 | Search CB1R | Search CB1R |
6 | AUTOTOMY BEHAVIOR | 1 | 50% | 0% | 1 | Search AUTOTOMY+BEHAVIOR | Search AUTOTOMY+BEHAVIOR |
7 | BIBENZYL CANNABINOID | 1 | 50% | 0% | 1 | Search BIBENZYL+CANNABINOID | Search BIBENZYL+CANNABINOID |
8 | CB RECEPTOR | 1 | 50% | 0% | 1 | Search CB+RECEPTOR | Search CB+RECEPTOR |
9 | DELTA 8 TETRAHYDROCANNABINOL | 1 | 50% | 0% | 1 | Search DELTA+8+TETRAHYDROCANNABINOL | Search DELTA+8+TETRAHYDROCANNABINOL |
10 | DEXANABINOL HU 211 | 1 | 50% | 0% | 1 | Search DEXANABINOL+HU+211 | Search DEXANABINOL+HU+211 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NORMOTENSIVE RABBITS | 33 | 72% | 13% | 26 |
2 | HU 211 | 12 | 56% | 7% | 15 |
3 | WIN55212 2 | 3 | 35% | 3% | 7 |
4 | TOPICAL ANANDAMIDES | 2 | 67% | 1% | 2 |
5 | TOPICAL DELTA 9 TETRAHYDROCANNABINOL | 1 | 100% | 1% | 2 |
6 | DELAYS PHOTORECEPTOR DEGENERATION | 1 | 50% | 0% | 1 |
7 | GLYCINE CURRENTS | 1 | 50% | 0% | 1 |
8 | EYE TISSUES | 0 | 20% | 1% | 2 |
9 | MARIHUANA SMOKING | 0 | 14% | 1% | 3 |
10 | CANNABINOID SENSITIVE RECEPTORS | 0 | 33% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection | 2008 | 17 | 95 | 31% |
Endocannabinoids in the retina: From marijuana to neuroprotection | 2008 | 45 | 229 | 15% |
Dexanabinol: A novel cannabinoid with neuroprotective properties | 2003 | 6 | 21 | 52% |
Nonpsychotropic synthetic cannabinoids | 2000 | 1 | 33 | 55% |
The cannabinoid system and visual processing: A review on experimental findings and clinical presumptions | 2015 | 0 | 138 | 24% |
OCULAR TOXICOLOGY OF MARIJUANA - AN UPDATE | 1987 | 1 | 36 | 72% |
Retrograde endocannabinoid inhibition of goldfish retinal cones is mediated by 2-arachidonoyl glycerol | 2007 | 6 | 93 | 15% |
Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CBI receptor agonist WIN 55212-2 | 2003 | 32 | 92 | 8% |
MARIHUANA AND THE EYE - A REVIEW | 1982 | 6 | 13 | 54% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TR LEE OCULAR PHARMACOL | 1 | 50% | 1.0% | 2 |
2 | CANNABINOID | 1 | 50% | 0.5% | 1 |
3 | NEUROBIOL COGNIT VISUELLE | 1 | 50% | 0.5% | 1 |
4 | AGNES GINGES HUMAN NEUROGENET NEUROL | 0 | 25% | 0.5% | 1 |
5 | INSERM 9501 | 0 | 25% | 0.5% | 1 |
6 | RAMON MARGALEF | 0 | 25% | 0.5% | 1 |
7 | SIR CHARLES TUPPER MED BLDG | 0 | 20% | 0.5% | 1 |
8 | SURG SCI ANESTHESIOL | 0 | 20% | 0.5% | 1 |
9 | UCHAD | 0 | 20% | 0.5% | 1 |
10 | INSERM U1114 | 0 | 14% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000215769 | ANANDAMIDE//FATTY ACID AMIDE HYDROLASE//CANNABINOID |
2 | 0.0000179289 | CANNABINOID//DELTA9 TETRAHYDROCANNABINOL//CANNABINOIDS |
3 | 0.0000097740 | CILIARY EPITHELIUM//AQUEOUS HUMOR FORMATION//AQUEOUS HUMOR SECRETION |
4 | 0.0000091228 | CANNABIS//MARIJUANA//NABIXIMOLS |
5 | 0.0000074627 | 11 NOR 9 CARBOXY DELTA9 TETRAHYDROCANNABINOL//MICROSOMAL ALDEHYDE OXYGENASE//11 NOR DELTA9 TETRAHYDROCANNABINOL 9 CARBOXYLIC ACID |
6 | 0.0000074355 | TRABECULAR MESHWORK//SCHLEMMS CANAL//OUTFLOW FACILITY |
7 | 0.0000071065 | ANTHROPOLOGIC MEDICINE//COBOLAMIN//HOLOGRAPHIC PARADIGM |
8 | 0.0000069800 | SEZ BOTTAZZI//SEZ F BOTTAZZI//UNIV RIC SVILUPPO GEST RISORSE AMBIENTE MAR |
9 | 0.0000068454 | EASTERN BLOTTING//CANNABIS SATIVA//THCA SYNTHASE GENE |
10 | 0.0000065849 | LINDEROL A//SKELETON TRANSFORMATION//ADUNCTIN B |